Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma
Open Access
- 12 December 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46718
Abstract
The management and prevention of childhood asthma remain significant challenges. Mendelian randomization (MR) has emerged as a valuable tool for identifying novel therapeutic targets. In response, we conducted a comprehensive, druggable genome-wide MR analysis to elucidate potential therapeutic targets for childhood asthma. Our study integrated genomic data concerning druggable targets, expression quantitative trait loci (eQTLs), and results from genome-wide association studies on childhood asthma. Employing the MR technique, we explored the putative causal links between genes that are targets for drugs and the development of childhood asthma. To validate these causal associations, we utilized reverse MR analyses along with colocalization techniques. Moreover, we performed enrichment analysis, mapped protein interaction networks, and executed drug prediction algorithms and molecular docking studies. These methodologies were applied to gain critical insights that could guide the development of more potent and precise therapeutic agents. We identified 35 druggable genes significantly associated with childhood asthma (including BLVRA, SLC9A3, LYZ, SRPK1, HOXA5, LYVE1, S100A9, ADORA1, RPL13, IL7R, SLFN11, SHMT1, CLN8, TOP1MT, LPAR5, RNASET2, ANK1, H6PD, DSP, CDC25B, VWF, ITK, CACNG6, ITGB7, S100A8, ADAM12, ST14, BMP6, HK2, SYK, ABCA1, ULK4, KBTBD2, SLCO4C1), with BLVRA showing promise as a target. Our research suggests that BLVRA may be a promising target for childhood asthma treatment, aiding in the prioritization of drug development for childhood asthma.Keywords
Funding Information
- Shandong Provincial Medical and Health Science and Technology Project (Number: 2023BJ000011, 2023BJ000016)
This publication has 72 references indexed in Scilit:
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variantsInternational Journal of Epidemiology, 2010
- Severe Exacerbations and Decline in Lung Function in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration.2006
- Heme Oxygenase-1-Mediated CD4+CD25high Regulatory T Cells Suppress Allergic Airway InflammationThe Journal of Immunology, 2006
- Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilatorsCochrane Database of Systematic Reviews, 2005
- Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant CyclePediatrics, 2004
- 5′-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes†Hepatology, 2004
- Transient Relief of Asthma Symptoms during Jaundice: A Possible Beneficial Role of BilirubinThe Tohoku Journal of Experimental Medicine, 2003
- Randomised controlled trial of aminophylline for severe acute asthmaArchives of Disease in Childhood, 1998
- Bilirubin Is an Antioxidant of Possible Physiological ImportanceScience, 1987